Pfizer Inc (PFE) stock
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3044% above fair value
$28.83−0.62 (-2.11%)
Close on Nov 12, 2026Market cap $164.32BP/E 41.2Yield 5.97%
Pfizer total assets
Total assets on the balance sheet at the end of each period.
Pfizer's total assets was $204.54B at Sep 27, 2026. For fiscal 2025 it was $208.16B, down 2.5% from the year before. Over ten years it grew 2.2% a year on average. The highest annual figure on record is $226.50B in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $208.16B | -2.5% |
| FY2024 | Dec 31, 2024 | $213.40B | -5.8% |
| FY2023 | Dec 31, 2023 | $226.50B | +14.9% |
| FY2022 | Dec 31, 2022 | $197.21B | +8.7% |
| FY2021 | Dec 31, 2021 | $181.48B | +17.7% |
| FY2020 | Dec 31, 2020 | $154.23B | -8.0% |
| FY2019 | Dec 31, 2019 | $167.59B | +5.1% |
| FY2018 | Dec 31, 2018 | $159.42B | -7.2% |
| FY2017 | Dec 31, 2017 | $171.80B | +0.1% |
| FY2016 | Dec 31, 2016 | $171.62B | +2.5% |
| FY2015 | Dec 31, 2015 | $167.38B | -0.1% |
| FY2014 | Dec 31, 2014 | $167.57B | -2.6% |
| FY2013 | Dec 31, 2013 | $172.10B | -7.4% |
| FY2012 | Dec 31, 2012 | $185.80B | -1.2% |
| FY2011 | Dec 31, 2011 | $188.00B | -3.6% |
| FY2010 | Dec 31, 2010 | $195.01B | -8.4% |
| FY2009 | Dec 31, 2009 | $212.95B | +91.6% |
| FY2008 | Dec 31, 2008 | $111.15B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 27, 2026 | $204.54B | -2.0% |
| Q2 FY2026 | Jun 28, 2026 | $201.13B | -2.4% |
| Q1 FY2026 | Mar 29, 2026 | $207.62B | -0.2% |
| Q4 FY2025 | Dec 31, 2025 | $208.16B | -2.5% |
| Q3 FY2025 | Sep 28, 2025 | $208.73B | -4.9% |
| Q2 FY2025 | Jun 29, 2025 | $206.10B | -4.7% |
| Q1 FY2025 | Mar 30, 2025 | $208.03B | -5.9% |
| Q4 FY2024 | Dec 31, 2024 | $213.40B | -5.8% |
| Q3 FY2024 | Sep 29, 2024 | $219.48B | +2.1% |
| Q2 FY2024 | Jun 30, 2024 | $216.19B | -1.8% |
| Q1 FY2024 | Mar 31, 2024 | $221.10B | +13.0% |
| Q4 FY2023 | Dec 31, 2023 | $226.50B | +14.9% |
| Q3 FY2023 | Oct 1, 2023 | $215.02B | +10.1% |
| Q2 FY2023 | Jul 2, 2023 | $220.17B | +12.7% |
| Q1 FY2023 | Apr 2, 2023 | $195.62B | +6.4% |
| Q4 FY2022 | Dec 31, 2022 | $197.21B | +8.7% |
| Q3 FY2022 | Oct 2, 2022 | $195.35B | +9.0% |
| Q2 FY2022 | Jul 3, 2022 | $195.29B | +14.9% |
| Q1 FY2022 | Apr 3, 2022 | $183.84B | +15.8% |
| Q4 FY2021 | Dec 31, 2021 | $181.48B | +17.7% |
| Q3 FY2021 | Oct 3, 2021 | $179.19B | +0.1% |
| Q2 FY2021 | Jul 4, 2021 | $169.92B | -4.5% |
| Q1 FY2021 | Apr 4, 2021 | $158.82B | -4.5% |
| Q4 FY2020 | Dec 31, 2020 | $154.23B | -8.0% |
| Q3 FY2020 | Sep 27, 2020 | $178.98B | +5.0% |
| Q2 FY2020 | Jun 28, 2020 | $177.93B | +13.9% |
| Q1 FY2020 | Mar 29, 2020 | $166.34B | +7.0% |
| Q4 FY2019 | Dec 31, 2019 | $167.59B | +5.1% |
| Q3 FY2019 | Sep 29, 2019 | $170.45B | +1.6% |
| Q2 FY2019 | Jun 30, 2019 | $156.20B | -5.3% |
| Q1 FY2019 | Mar 31, 2019 | $155.42B | -5.6% |
| Q4 FY2018 | Dec 31, 2018 | $159.42B | -7.2% |
| Q3 FY2018 | Sep 30, 2018 | $167.84B | -2.5% |
| Q2 FY2018 | Jul 1, 2018 | $164.98B | -2.1% |
| Q1 FY2018 | Apr 1, 2018 | $164.61B | -2.5% |
| Q4 FY2017 | Dec 31, 2017 | $171.80B | +0.1% |
| Q3 FY2017 | Oct 1, 2017 | $172.15B | – |
| Q2 FY2017 | Jul 2, 2017 | $168.56B | – |
| Q1 FY2017 | Apr 2, 2017 | $168.78B | – |
| Q4 FY2016 | Dec 31, 2016 | $171.62B | – |
See a number that looks wrong?